The Second Trump White House Could Drastically Reshape Infectious Disease Research. Here’s What’s at Stake.
Research by the Center for Integration of Science and Industry is featured for revealing that public funds from the National Institutes of Health paid for most of the research that led to every new pharmaceutical drug approved from 2010 to 2019.